Recent News

• 03.07.2025 - Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules
• 02.14.2025 - Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates
• 02.04.2025 - Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board
• 01.23.2025 - Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea
• 12.03.2024 - Hello world!

Recent Filings

• 02.14.2025 - 8-K Current report
• 02.14.2025 - EX-99.1 EX-99.1
• 02.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 02.04.2025 - EX-99.1 EX-99.1
• 02.04.2025 - 8-K Current report
• 01.23.2025 - 8-K Current report
• 01.10.2025 - 8-K Current report
• 12.11.2024 - 8-K Current report
• 12.06.2024 - 424B3 Prospectus [Rule 424(b)(3)]
• 12.06.2024 - EFFECT Notice of Effectiveness